Matches in Wikidata for { <http://www.wikidata.org/entity/Q91766761> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91766761 description "article scientifique publié en 2020" @default.
- Q91766761 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91766761 description "scientific article published on 06 April 2020" @default.
- Q91766761 description "wetenschappelijk artikel" @default.
- Q91766761 description "наукова стаття, опублікована 6 квітня 2020" @default.
- Q91766761 name "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 name "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 type Item @default.
- Q91766761 label "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 label "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 prefLabel "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 prefLabel "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 P1433 Q91766761-0DA0CFA6-194B-4674-A720-75BF94FCC051 @default.
- Q91766761 P1476 Q91766761-1CF997C1-39FC-4A74-8E4C-7FA6E6C9949F @default.
- Q91766761 P2093 Q91766761-064BC7C1-C5E4-4DE2-B30D-C9530BA28B0F @default.
- Q91766761 P2093 Q91766761-148F081D-6413-4054-B56B-AC2439F819B8 @default.
- Q91766761 P2093 Q91766761-19D63580-0FB2-4F55-874A-A4389811C61B @default.
- Q91766761 P2093 Q91766761-407609F4-493E-4B21-BCC7-F8A73F4FE9C2 @default.
- Q91766761 P2093 Q91766761-4C3C2D23-C6BF-4965-B96F-FBA03620B0D2 @default.
- Q91766761 P2093 Q91766761-76D17BF4-6AC9-45B8-BEF8-0F5F5373F74B @default.
- Q91766761 P2093 Q91766761-9E708CB2-1874-419F-B1A4-502306A95904 @default.
- Q91766761 P2093 Q91766761-ECC5594D-8BE2-4B60-9105-BDE7DF5010AC @default.
- Q91766761 P31 Q91766761-7D1D7355-7A91-4628-A179-1C46E5EC00A3 @default.
- Q91766761 P356 Q91766761-9DF482A4-F5F8-4749-972A-CAB79AF5C03B @default.
- Q91766761 P577 Q91766761-5A3193B7-B8D4-496C-9933-870E9F4A71A3 @default.
- Q91766761 P698 Q91766761-17AB2162-20A2-4501-B954-9D6057D04167 @default.
- Q91766761 P921 Q91766761-9028FBE9-400A-4100-B94D-1A96A6C46081 @default.
- Q91766761 P356 J.CANLET.2020.04.001 @default.
- Q91766761 P698 32272148 @default.
- Q91766761 P1433 Q326372 @default.
- Q91766761 P1476 "Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma" @default.
- Q91766761 P2093 "Chengming Liu" @default.
- Q91766761 P2093 "Hecheng Li" @default.
- Q91766761 P2093 "Jie He" @default.
- Q91766761 P2093 "Nan Sun" @default.
- Q91766761 P2093 "Runsen Jin" @default.
- Q91766761 P2093 "Ruochuan Zang" @default.
- Q91766761 P2093 "Sufei Zheng" @default.
- Q91766761 P2093 "Xinfeng Wang" @default.
- Q91766761 P31 Q13442814 @default.
- Q91766761 P356 "10.1016/J.CANLET.2020.04.001" @default.
- Q91766761 P577 "2020-04-06T00:00:00Z" @default.
- Q91766761 P698 "32272148" @default.
- Q91766761 P921 Q16909647 @default.